Association of Microvascular Dysfunction With Late-Life Depression

A newly published systematic review and meta-analysis examines the association between microvascular dysfunction and late-life depression! 
#Psychiatry #Depression
The article from JAMA Network:
http://jamanetwork.com/journals/jamapsychiatry/article-abstract/2629521?utm_source=FBPAGE&utm_medium=social_jn&utm_term=902414869&utm_content=content_engagement%7carticle_engagement&utm_campaign=article_alert&linkId=38204922

Comments

Post a Comment

Popular posts from this blog

First New Drug for Liver Cancer in a Decade: Regorafenib

The US Food and Drug Administration (FDA) has expanded the indication for regorafenib ( Stivarga , Bayer) to now include treatment for patients with hepatocellular carcinoma (HCC) who have previously been treated with the drug sorafenib ( Nexavar , Bayer). Expansion of regorafenib's indication marks the first FDA-approved treatment for a liver cancer in almost a decade! Medscape article: http://www.medscape.com/viewarticle/879216?src=soc_fb_170427_mscpedt_news_onc_livercancer
Read more